Adenoid cystic carcinoma: A review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adenoid cystic carcinoma: A review of clinical features, treatment targets and advancement in improving the immune response to monoclonal antibody therapy
Authors
Keywords
Adenoid cystic carcinoma, treatment targets, immunotherapy, prochlorperazine, antibody dependent cellular cytotoxicity, monoclonal antibody therapy
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume -, Issue -, Pages 188523
Publisher
Elsevier BV
Online
2021-02-17
DOI
10.1016/j.bbcan.2021.188523
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life
- (2020) Laura D. Locati et al. CANCER
- Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- (2020) Maria V. Yusenko et al. CANCER LETTERS
- The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype
- (2020) Luc GT Morris et al. CLINICAL CANCER RESEARCH
- Investigating PSMA-targeted radioligand therapy efficacy as a function of cellular PSMA levels and intra-tumoral PSMA heterogeneity
- (2020) Kyle Current et al. CLINICAL CANCER RESEARCH
- Should a neck dissection be performed on patients with cN0 adenoid cystic carcinoma? A REFCOR propensity score matching study
- (2020) Sarah Atallah et al. EUROPEAN JOURNAL OF CANCER
- PD-L1 and PD-L2 Expression Levels Are Low in Primary and Secondary Adenoid Cystic Carcinomas of the Orbit
- (2020) Natalie Wolkow et al. OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY
- Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
- (2020) Aviad Ben-Shmuel et al. Frontiers in Immunology
- Scientifically based combination therapies with immuno‐oncology checkpoint inhibitors
- (2020) Hui Yi Chew et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies
- (2020) Hui Yi Chew et al. CELL
- Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma.
- (2020) Bhumsuk Keam et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
- (2020) Bob T. Li et al. Cancer Discovery
- Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma
- (2020) Glenn J. Hanna et al. ORAL ONCOLOGY
- Acute statin treatment improves antibody accumulation in EGFR- and PSMA-expressing tumors
- (2020) Patricia M.R. Pereira et al. CLINICAL CANCER RESEARCH
- Acetylation-dependent regulation of PD-L1 nuclear translocation dictates the efficacy of anti-PD-1 immunotherapy
- (2020) Yang Gao et al. NATURE CELL BIOLOGY
- The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
- (2020) Katie Hudson et al. Frontiers in Immunology
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- Impact of lymph node sampling on survival in cN0 major salivary gland adenoid cystic carcinoma
- (2019) Zhen Jason Qian et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation
- (2019) Ashley Cornett et al. EBioMedicine
- Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas
- (2019) Takafumi Nakano et al. ORAL ONCOLOGY
- The Role of Elective Neck Dissection in Patients With Adenoid Cystic Carcinoma of the Head and Neck
- (2019) Roy Xiao et al. LARYNGOSCOPE
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
- (2019) Marlon Perera et al. EUROPEAN UROLOGY
- A phase I/II trial of cetuximab in combination with interleukin-12 administered to patients with unresectable primary or recurrent head and neck squamous cell carcinoma
- (2019) Elizabeth L McMichael et al. CLINICAL CANCER RESEARCH
- Safety and clinical activity of the Notch inhibitor, crenigacestat (LY3039478), in an open-label phase I trial expansion cohort of advanced or metastatic adenoid cystic carcinoma
- (2019) C. Even et al. INVESTIGATIONAL NEW DRUGS
- Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma
- (2019) Vatche Tchekmedyian et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.
- (2019) Jonathan Daniel Schoenfeld et al. JOURNAL OF CLINICAL ONCOLOGY
- NISCAHN: A phase II, multicenter nonrandomized trial aiming at evaluating nivolumab (N) in two cohorts of patients (pts) with recurrent/metastatic (R/M) salivary gland carcinoma of the head and neck (SGCHN), on behalf of the Unicancer Head & Neck Group.
- (2019) Jerome Fayette et al. JOURNAL OF CLINICAL ONCOLOGY
- Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
- (2019) Patricia MR Pereira et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic importance of the lymphovascular invasion in head and neck adenoid cystic carcinoma: A systematic review and meta-analysis
- (2019) Bárbara Martins-Andrade et al. ORAL ONCOLOGY
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma
- (2019) Allen S. Ho et al. JOURNAL OF CLINICAL INVESTIGATION
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
- (2019) Wenxiu Wang et al. CANCER LETTERS
- Lenvatinib in Management of Solid Tumors
- (2019) Zhonglin Hao et al. ONCOLOGIST
- MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma
- (2019) Yue Jiang et al. ORAL ONCOLOGY
- Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
- (2019) Amaia Eleonora Maennling et al. Cancers
- The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck
- (2019) Sebastian Adeberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Advanced adenoid cystic carcinoma of the skull base – The role of surgery
- (2019) Emily Guazzo et al. ORAL ONCOLOGY
- A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors
- (2018) R Ferrarotto et al. ANNALS OF ONCOLOGY
- Toxicities Associated With PD-1/PD-L1 Blockade
- (2018) Daniel Y. Wang et al. CANCER JOURNAL
- Peptidomimetic blockade of MYB in acute myeloid leukemia
- (2018) Kavitha Ramaswamy et al. Nature Communications
- Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma
- (2018) Kosuke Saida et al. Oncotarget
- Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT
- (2018) Thomas J.W. Klein Nulent et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- Programmed Cell Death Ligand 1 (PD-L1) Signaling Regulates Macrophage Proliferation and Activation
- (2018) Genevieve P Hartley et al. Cancer Immunology Research
- Cervical lymph node metastases in salivary gland adenoid cystic carcinoma: a systematic review and meta-analysis
- (2018) Chunliu Ning et al. Cancer Management and Research
- Phase II trial of apatinib in patients with recurrent and/or metastatic adenoid cystic carcinoma of the head and neck: Updated analysis.
- (2018) Guopei Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- An ex vivo human tumour assay reveals distinct patterns of EGFR trafficking in squamous cell carcinoma correlating to therapeutic outcomes
- (2018) Shannon R. Joseph et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line
- (2018) Kristy A. Warner et al. ORAL ONCOLOGY
- Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands
- (2018) Carla Mosconi et al. ORAL ONCOLOGY
- Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis
- (2017) Thomas J. W. Klein Nulent et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeting the transcription factor Myb by small-molecule inhibitors
- (2017) Sagar Uttarkar et al. EXPERIMENTAL HEMATOLOGY
- Defining the surgical margins of adenoid cystic carcinoma and their impact on outcome: An international collaborative study
- (2017) Moran Amit et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- MYB ,MYBL1 ,MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma
- (2017) Kana Fujii et al. HISTOPATHOLOGY
- Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells
- (2017) Maria Carmen Ochoa et al. IMMUNOLOGY AND CELL BIOLOGY
- Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors
- (2017) Renata Ferrarotto et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Targeting acute myeloid leukemia by drug-induced c-MYB degradation
- (2017) V Walf-Vorderwülbecke et al. LEUKEMIA
- Risk of Nodal Metastasis in Major Salivary Gland Adenoid Cystic Carcinoma
- (2017) Uchechukwu C. Megwalu et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Lutetium-177-labelled anti-prostate-specific membrane antigen antibody and ligands for the treatment of metastatic castrate-resistant prostate cancer: a systematic review and meta-analysis
- (2017) R J S Calopedos et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
- (2017) Hyeyoon Chang et al. OncoTargets and Therapy
- Taking it up a NOTCH: anovel subgroup of ACC is identified
- (2017) Renata Ferrarotto et al. Oncotarget
- Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
- (2017) Sook-Kyoung Heo et al. Scientific Reports
- [177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent
- (2017) Margret Schottelius et al. Theranostics
- Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling
- (2017) Mattias K. Andersson et al. JNCI-Journal of the National Cancer Institute
- Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy
- (2017) Weiqiang Zhou et al. CURRENT MEDICINAL CHEMISTRY
- The growing world of CAR T cell trials: a systematic review
- (2016) Astrid Holzinger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients
- (2016) S. Trivedi et al. CLINICAL CANCER RESEARCH
- In Vivo Visualization of Prostate-Specific Membrane Antigen in Adenoid Cystic Carcinoma of the Salivary Gland
- (2016) Susanne Lütje et al. CLINICAL NUCLEAR MEDICINE
- Differences in patterns of survival in metastatic adenoid cystic carcinoma of the head and neck
- (2016) Stijn van Weert et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Characterization and localization of c-kit and epidermal growth factor receptor in different patterns of adenoid cystic carcinoma
- (2016) Anshi Jain et al. Journal of Cancer Research and Therapeutics
- Multiple routes of endocytic internalization of PDGFRβ contribute to PDGF-induced STAT3 signaling
- (2016) Kamil Jastrzębski et al. JOURNAL OF CELL SCIENCE
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- Cervical lymph node metastasis in adenoid cystic carcinoma of the major salivary glands
- (2016) JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Management of Salivary Gland Tumours: United Kingdom National Multidisciplinary Guidelines
- (2016) S Sood et al. JOURNAL OF LARYNGOLOGY AND OTOLOGY
- Patient-derived xenograft (PDX) tumors increase growth rate with time
- (2016) Alexander T. Pearson et al. Oncotarget
- VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma
- (2016) Seongyeol Park et al. Cancer Research and Treatment
- The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis
- (2016) Jun Ju et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- An Overview of Head and Neck Malignancy with Perineural Spread
- (2016) Benedict Panizza Journal of Neurological Surgery Part B-Skull Base
- The Natural History and Treatment Outcomes of Perineural Spread of Malignancy within the Head and Neck
- (2016) Timothy Warren et al. Journal of Neurological Surgery Part B-Skull Base
- Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes
- (2016) V. Sridharan et al. Cancer Immunology Research
- Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors
- (2015) S. J. Wong et al. ANNALS OF ONCOLOGY
- Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations
- (2015) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Phase II study of gefitinib in patients with advanced salivary gland cancers
- (2015) John A. Jakob et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
- (2015) F Guo et al. ONCOGENE
- Adenoid cystic carcinoma of the head and neck – An update
- (2015) Andrés Coca-Pelaz et al. ORAL ONCOLOGY
- Salivary adenoid cystic carcinoma in Denmark 1990–2005: Outcome and independent prognostic factors including the benefit of radiotherapy. Results of the Danish Head and Neck Cancer Group (DAHANCA)
- (2015) Kristine Bjørndal et al. ORAL ONCOLOGY
- Histopathological grading of adenoid cystic carcinoma of the head and neck: Analysis of currently used grading systems and proposal for a simplified grading scheme
- (2015) Stijn van Weert et al. ORAL ONCOLOGY
- Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma
- (2015) K. J. Brayer et al. Cancer Discovery
- Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling
- (2015) Young Kwang Chae et al. Oncotarget
- NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma
- (2015) Bo-Hua Su et al. Oncotarget
- Elective Neck Dissection in Patients With Head and Neck Adenoid Cystic Carcinoma: An International Collaborative Study
- (2014) Moran Amit et al. ANNALS OF SURGICAL ONCOLOGY
- A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma
- (2014) Dong-Wan Kim et al. BMC CANCER
- Incidence of cervical lymph node metastasis and its association with outcomes in patients with adenoid cystic carcinoma. An international collaborative study
- (2014) Moran Amit et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- CXCR4 antagonist inhibits perineural invasion of adenoid cystic carcinoma
- (2014) Woo-Jin Jeong et al. JOURNAL OF CLINICAL PATHOLOGY
- Development and characterization of salivary adenoid cystic carcinoma cell line
- (2014) Jie Li et al. ORAL ONCOLOGY
- Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation
- (2014) Yuuki Obata et al. Nature Communications
- Peripheral Nerve-Derived CXCL12 and VEGF-A Regulate the Patterning of Arterial Vessel Branching in Developing Limb Skin
- (2013) Wenling Li et al. DEVELOPMENTAL CELL
- Analysis of failure in patients with adenoid cystic carcinoma of the head and neck. An international collaborative study
- (2013) Moran Amit et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Whole exome sequencing of adenoid cystic carcinoma
- (2013) Philip J. Stephens et al. JOURNAL OF CLINICAL INVESTIGATION
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- The mutational landscape of adenoid cystic carcinoma
- (2013) Allen S Ho et al. NATURE GENETICS
- Adenoid cystic carcinoma of the head and neck: A single-center analysis of 105 consecutive cases over a 30-year period
- (2013) Stijn van Weert et al. ORAL ONCOLOGY
- Endocytosis and Cancer
- (2013) I. Mellman et al. Cold Spring Harbor Perspectives in Biology
- Adenoid cystic carcinoma of the head and neck
- (2012) Christopher L. Ellington et al. CANCER
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
- (2012) Rafael Rosell et al. LANCET ONCOLOGY
- Role and potential for therapeutic targeting of MYB in leukemia
- (2012) D R Pattabiraman et al. LEUKEMIA
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
- (2012) Sandra Misale et al. NATURE
- Cetuximab therapy in head and neck cancer: Immune modulation with interleukin-12 and other natural killer cell–activating cytokines
- (2012) Eric Luedke et al. SURGERY
- A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC
- (2011) N. G. Chau et al. ANNALS OF ONCOLOGY
- Prognosis and risk factors for early-stage adenoid cystic carcinoma of the major salivary glands
- (2011) Mihir K. Bhayani et al. CANCER
- A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry
- (2011) Nan Li et al. CANCER
- Development and characterization of xenograft model systems for adenoid cystic carcinoma
- (2011) Christopher A Moskaluk et al. LABORATORY INVESTIGATION
- Salivary gland carcinoma in Denmark 1990–2005: A national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)
- (2011) Kristine Bjørndal et al. ORAL ONCOLOGY
- Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance
- (2010) Y. Mitani et al. CLINICAL CANCER RESEARCH
- Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review
- (2010) Giorgos Papaspyrou et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review
- (2010) Scott A Laurie et al. LANCET ONCOLOGY
- Epirubicin, Cisplatin and Protracted Venous Infusion 5-Fluorouracil Chemotherapy for Advanced Salivary Adenoid Cystic Carcinoma
- (2009) P.J. Ross et al. CLINICAL ONCOLOGY
- Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection
- (2009) Agnes Oplatek et al. LARYNGOSCOPE
- Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)
- (2009) Laura D. Locati et al. ORAL ONCOLOGY
- Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2
- (2009) Janyaporn Phuchareon et al. PLoS One
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
- (2009) M. Persson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer
- (2009) Philipp Wolf et al. PROSTATE
- Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)
- (2008) C.M.L. van Herpen et al. EUROPEAN JOURNAL OF CANCER
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity
- (2008) M Scaltriti et al. ONCOGENE
- Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study
- (2008) L.D. Locati et al. ORAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search